Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

 Gastro/
Procto/
Nutrition		 MICI Pancréas
A. LIEVRE V. VALANTIN I. ROSA P. JOUET S. NAHON V. REBOURS

V. HAUTEFEUILLE
N. WILLIET
N. FARES
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
PE. RAUTOU

H. DAMON
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre décroissant Titre Date Coup de coeur Thématique
Clinical Gastroenterology and Hepatology Characteristics and Progression of Preclinical Inflammatory Bowel Disease. sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease. mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Consumption of Red and Processed Meat and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis avr. 17 3 ♥ Pancréas/voies bilaires
Clinical Gastroenterology and Hepatology Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Education, Employment, Income, and Marital Status Among Adults Diagnosed With Inflammatory Bowel Diseases During Childhood or Adolescence avr. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Biologics Delay Progression of Crohn’s Disease, but Not Early Surgery, in Children sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Features of Patients With Crohn's Disease and Hidradenitis Suppurativa. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort fév. 17 2 ♥ Pancréas
Clinical Gastroenterology and Hepatology Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn's Disease. avr. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features sep. 18 3 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study juin. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. juin. 16 2 ♥ MICI
Clinical Gastroenterology and Hepatology Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis avr. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis. avr. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. oct. 16 3 ♥ MICI

Pages